| Literature DB >> 22473597 |
Jennifer Lafemina1, Murray F Brennan.
Abstract
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity, heterogeneity, and a lack of a comprehensive understanding of the pathogenesis, little progress has been made in treatment and outcomes. The current review explores the past, present, and future of the understanding and treatment of this disease process.Entities:
Mesh:
Year: 2012 PMID: 22473597 DOI: 10.1002/jso.23112
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454